Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Archives of Rheumatology|December 4, 2023
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure databaseEmine Duygu Ersözlü, Mustafa Ekici, Belkis Nihan Coşkun, et al.
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
European Journal of Rheumatology|January 11, 2020
Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registrySibel Zehra Aydın, Gezmiş Kimyon, Cem Özişler, et al.
Archives of Rheumatology|April 23, 2025
Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experienceElif Durak Ediboglu, Umut Kalyoncu, Dilek Solmaz, et al.
Rheumatology (Oxford, England)|October 31, 2016
The Psoriatic Arthritis Registry of Turkey: results of a multicentre registry on 1081 patientsUmut Kalyoncu, Özün Bayindir, Mustafa Ferhat Öksüz, et al.
Rheumatology (Oxford, England)|June 24, 2023
The predictors of paradoxical reactions, especially psoriasis, to biologic therapy-findings from the TReasure database: a 5-year follow-up studyBurcu Yagiz, Nihal Lermi, Belkis N Coskun, et al.
Rheumatology International|July 6, 2021
In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?Burcu Yagiz, Belkis Nihan Coskun, Yavuz Pehlivan, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure RegistryOmer Karadag, Bayram Farisogullari, Burcu Yagiz, et al.
International Journal of Rheumatic Diseases|May 13, 2025
Real-World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney DiseaseDilara Bulut Gökten, Mehmet Engin Tezcan, Burcu Yağız, et al.
Clinical Rheumatology|June 28, 2018
Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real lifeSibel Zehra Aydin, Orhan Kucuksahin, Levent Kilic, et al.
Pageof 17